ABTECT-2 - ABX464-106 Treatment Evaluation for ulc
A randomized, double-blind, placebo-controlled, multicenter phase III study to evaluate the efficacy and safety of ABX464 once daily for induction treatment in subjects with moderately to severely active ulcerative colitis
- Sex at Birth: Any
- Age: Adult (18 - 64), Older Adult (65+)
- Accepting Healthy People: No
- Type: Interventional / Therapeutic
- Trial Phase: Phase III
- Conditions Being Studied: Colon, Rectum, Ulcerative Colitis
Study Purpose
The purpose of this clinical research study is to look at whether the study drug, Obefazimod, works, and whether it is safe when given to subjects with ulcerative colitis (UC).
Locations
UH Ahuja Medical Center
3999 Richmond Road
Beachwood OH, 44122
UH Cleveland Medical Center
11100 Euclid Avenue
Cleveland OH, 44106
- UH IRB: STUDY20230065
- StudyID: 2022-01013
- ClinicalTrials.gov: NCT05507216
Questions or concerns? We're here to help.
Non-cancer Trials: 1-833-78TRIAL or Contact Us Online
Cancer Trials: 1-800-641-2422